Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company CARsgen Therapeutics Co. Ltd.
DescriptionChimeric antigen receptor T-cells (CAR-T) targeting the epidermal growth factor receptor (EGFR)
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationBrain cancer
Indication DetailsTreat glioblastoma multiforme (GBM)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today